Judy Ann Bracey, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 W Semands St, Conroe, TX 77301 Phone: 936-756-5598 |
Pecolia Rencher, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 W Semands St, Conroe, TX 77301 Phone: 936-756-5598 |
Omowunmi Oluwatosin Ojo, LPN Licensed Practical Nurse Medicare: Medicare Enrolled Practice Location: 704 Longmire Rd Ste 243, Conroe, TX 77304 Phone: 936-668-1479 |
Ms. Keesha Lewis, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3115 College Park Drive, Suite 104, Conroe, TX 77384 Phone: 936-321-5030 Fax: 936-271-5033 |
Kelly D Jackson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 W Semands St, Conroe, TX 77301 Phone: 936-756-5598 |
Quincy Lantier, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 W Semands St, Conroe, TX 77301 Phone: 936-756-5598 |
Pamela Joyce Jones, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3115 College Park Dr, Suite 104, Conroe, TX 77384 Phone: 936-321-5030 Fax: 936-271-5033 |
Mercygrace Nyambura Ndungu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 W Semands St, Conroe, TX 77301 Phone: 936-756-5598 Fax: 936-249-2244 |
News Archive
The University of Barcelona and Hospital ClĂnic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic and antifibrotic drug, for the treatment of lung cancer.
Superantigens, the toxins produced by staphylococcus bacteria, are more complex than previously believed, reveals a team of researchers from the University of Gothenburg in an article published today in the scientific journal Nature Communications. Their discovery shows that the body's immune system can cause more illnesses than realised.
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius released the following statement today on WellPoint's announcement that it intends to end the practice of rescinding patients' coverage in advance of the Affordable Care Act's requirement that insurers stop this practice starting this fall. WellPoint's announcement comes after Secretary Sebelius sent a letter on April 22 urging the company to immediately stop the practice of rescinding coverage for patients who become ill.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Contrary to popular notions, people at the high end of the autism spectrum disorder continuum suffer most from an inability to model "self" rather than impaired ability to respond to others, said Baylor College of Medicine researchers in a report that appear in the journal Neuron.
› Verified 8 days ago